Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 5 results for "r sivarajah"

Rosiglitazone Did Not Induce Acute Kidney Injury in Normochole...

References Yki-Järvinen H: Thiazolidinediones. N Engl J Med 2004;351:1106-1118. Abdelrahman M, Sivarajah A, Thiemermann C: Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Sexual Development, 6 days ago

1 images for "r sivarajah"

The Hindu, 6 months ago

Daily Kos Elections Morning Digest: Fourth straight poll shows Pryor up as Cotton seeks debates

Want the scoop on hot races around the country? Get the digest emailed to you each weekday morning. Sign up here . Leading Off : • AR-Sen : Well whaddya know. We now have four straight polls showing Democratic Sen. Mark Pryor leading GOP Rep.
 Daily Kos3 days ago

Bachmann Endorses Emmer as Successor in Minnesota

By Posted at 1:15 p.m. today Emmer is sporting a new endorsement. (Tom Williams/CQ Roll Call File Photo) Retiring Rep. Michele Bachmann, R-Minn., on Tuesday endorsed former state Rep. Tom Emmer as her successor in her soon-to-be former ...
 Roll Call Online2 days ago

Madurai-based techie develops augmented reality game

MADURAI: Augmented reality games may be in their nascent stage in tier-I cities like Chennai. But, that hasn't deterred the passion of this Madurai-based game developer, who has come up with trial version of an augmented reality game titled 'Zombies ...
 Times of India1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less